Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Healthcare Industry News Technology Industry News EPAM Systems acquires Odysseus Data Services to bolster health data analytics capabilities In a significant move within the digital transformation and health analytics sectors, EPAM Systems, Inc. (NYSE: EPAM) has… byPallavi MadhirajuJune 14, 2024